Most clinics will skip this. We won't. Here's exactly who qualifies for each OPTML protocol, who shouldn't be on it, and what we screen for at intake.
Eligibility, MTC/MEN2 history, pancreatitis, gallbladder, pregnancy, and the screening labs we require.
Read full screening →Why microdose has a wider eligibility window, and the cases where it still isn't right.
Read full screening →Hematocrit, PSA, fertility plans, prostate cancer history, sleep apnea, and the labs we need to see.
Read full screening →Who enclomiphene is built for, why it's the fertility-sparing option, and when TRT is still the better path.
Read full screening →VTE history, breast cancer, undiagnosed bleeding, migraines with aura, and the timing question that matters.
Read full screening →Active malignancy, severe illness, and why we screen IGF-1 before and during therapy.
Read full screening →The contraindication list is short, but the conditions matter. Histamine, pregnancy, and active cancer.
Read full screening →OPTML offers compounded semaglutide and tirzepatide, prescribed and overseen by U.S.-licensed physicians. Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. OPTML is not associated with, endorsed by, or affiliated with the manufacturers of FDA-approved branded weight-loss medications, and does not sell or supply those branded products. Anyone interested in an FDA-approved branded medication should consult a licensed healthcare provider or pharmacist. Individual results vary; no specific result is promised, and weight management requires ongoing medical guidance.
The whole picture in one sitting: who it suits, what the labs decide, what the first year actually looks like. Every clinical claim is cited.
How to protect lean mass while losing weight on a GLP-1.
Double-check your email. A typo means we cannot reach you or resend your guide.
We will send occasional emails you can unsubscribe from at any time. See our Privacy Policy.